Sign in
Anti-proteinuric therapy and Fabry nephropathy; factors associated with preserved kidney function during agalsidase-beta therapy
Abstract   Peer reviewed

Anti-proteinuric therapy and Fabry nephropathy; factors associated with preserved kidney function during agalsidase-beta therapy

David G. Warnock, Christie P. Thomas, Bojan Vujkovac, Ruth C. Campbell, Joel Charrow, Dawn A. Laney, Leslie L. Jackson, William R. Wilcox and Christoph Wanner
Molecular genetics and metabolism, Vol.117(2), pp.S120-S120
02/2016
DOI: 10.1016/j.ymgme.2015.12.484

View Online

Details

Metrics

6 Record Views